Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity
(2023). Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity. EKB Journal Management System, 3(2), -. doi: 10.21608/esdlj.2023.456214
. "Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity". EKB Journal Management System, 3, 2, 2023, -. doi: 10.21608/esdlj.2023.456214
(2023). 'Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity', EKB Journal Management System, 3(2), pp. -. doi: 10.21608/esdlj.2023.456214
Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity. EKB Journal Management System, 2023; 3(2): -. doi: 10.21608/esdlj.2023.456214

Study of the Level of Cystatin C in Type 2 Diabetes Mellitus with Obesity

Egyptian Society of Diabetes and Lipidology Journal
Volume 3, Issue 2, October 2023    PDF (792.09 K)
Document Type: Abstracts
DOI: 10.21608/esdlj.2023.456214
Abstract
Obesity is a major factor in metabolic disorders and premature deaths in developing countries. The risk of type 2 diabetes mellitus (DM) increases many folds in association with obesity. Cystatin C is an early marker for nephropathy, and it can also predict peripheral neuropathy, retinopathy and arterial sclerosis apart from renal function. Cystatin C is also associated with Cardiovascular events and limb ischemia Associated complications deteriorate the quality of life of patients and increase the morbidity rate.
Statistics
Article View: 1